Lemalesomab

Lemalesomab is a mouse monoclonal antibody for the diagnosis of inflammatory lesions.^[1][2]

Lemalesomab

Monoclonal antibody
Type	Whole antibody
Source	Mouse
Target	NCA-90 (granulocyte antigen)
Clinical data
ATC code	none
Identifiers
CAS Number	250242-54-7 N
ChemSpider	none
UNII	018649S21N
NY (what is this?)  (verify)

References

1. "International Nonproprietary Names (INN) for Pharmaceutical Substances Proposed INN: List 84" (PDF). WHO Drug Information. 14 (4): 260. 2000.
2. Pelletier JP (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic concepts in transfusion medicine. Philadelphia: Elsevier. p. 296. doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. S2CID 213508934.